SoFi stock price slides 5% as risk-off hits growth names; what traders watch next
5 February 2026
1 min read

SoFi stock price slides 5% as risk-off hits growth names; what traders watch next

New York, Feb 5, 2026, 15:29 EST — Regular session underway.

  • SoFi Technologies shares fell about 5% in afternoon trading, extending a turbulent week for fintech lenders
  • JPMorgan’s upgrade earlier this week failed to stop the stock’s slide after the company laid out its 2026 forecast
  • Next week’s delayed U.S. jobs and inflation data are in investors’ sights for fresh hints on interest rate moves

Shares of SoFi Technologies, Inc (SOFI) fell 5.3% to $19.65 Thursday afternoon, down from $20.75 at Wednesday’s close. The stock touched a session low of $19.20.

The drop follows investors reevaluating SoFi’s growth projections after the company set 2026 targets that call for about 30% adjusted net revenue growth and roughly $1.6 billion in adjusted EBITDA, a profit measure excluding some one-time expenses. Management also forecasted around $1.04 billion in adjusted net revenue for Q1. 1

JPMorgan upgraded SoFi to “Overweight” on Tuesday, maintaining its $31 price target. Analyst Reginal Smith pointed to the recent post-earnings pullback as an opportunity to buy, citing solid momentum fueled by growth in members and deposits. 2

SoFi slipped on Thursday during a widespread selloff, sparked by doubts over Big Tech’s AI spending plans. “There’s a lot of uncertainty about whether these bets will pay off,” noted Tom Hainlin, investment strategist at U.S. Bank Wealth Management, as the S&P 500 and Nasdaq each fell about 1%. 3

Other consumer-lending and fintech stocks fell as well: Affirm tumbled about 5%, Upstart plunged more than 8%, and LendingClub declined close to 2%.

On Wall Street, an “Overweight” rating signals the analyst’s belief that the stock will outperform its peers. JPMorgan’s target hinges on the PEG ratio, which tweaks the price-to-earnings multiple by factoring in growth rate.

For a lender, the trade can reverse fast when markets turn defensive. If credit costs rise or new member growth falters, investors pivot sharply from long-term targets to focus on near-term earnings results.

Focus turns to next week’s postponed U.S. January jobs report, now due Feb. 11, followed by the January Consumer Price Index data on Feb. 13. These key numbers might upend interest rate expectations, impacting borrowing costs, funding conditions, and sentiment around high-growth finance stocks. 4

Stock Market Today

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

8 February 2026
Cambricon Technologies shares closed at 1,036.99 yuan in Shanghai on Friday, down 2.02%, with volume at about 8 million shares. The stock has fallen roughly 16.5% since Feb. 2 after sharp declines earlier in the week. Investors await the company’s next earnings report, due March 13, for confirmation of its forecasted profit turnaround. Cambricon is valued at about 437.28 billion yuan.
Infineon stock in focus after Friday rise as reports flag April price hikes for power chips

Infineon stock in focus after Friday rise as reports flag April price hikes for power chips

8 February 2026
Infineon shares closed up 1.5% at 42.04 euros Friday on Xetra after reports the company plans April price hikes on some power products. TrendForce said the increases, citing tight supply and higher costs, would apply from April 1. The Feb. 12 record date and Feb. 19 annual meeting are next for shareholders. UBS raised its price target to 47 euros, citing stronger margins.
TE Connectivity stock jumps 3.5% into the weekend — what to watch for TEL next week

TE Connectivity stock jumps 3.5% into the weekend — what to watch for TEL next week

8 February 2026
TE Connectivity (NYSE: TEL) closed Friday up 3.46% at $215.91, rebounding after a 3.29% drop Thursday, but remains 5% lower for the week and 14% below its 52-week high. The company expects to close a $750 million senior notes offering on Monday and pay a $0.71 dividend March 13. Investors await Friday’s U.S. CPI report, seen as a key market driver.
TransCode Therapeutics stock jumps on FDA filing for Phase 2a colorectal cancer trial
Previous Story

TransCode Therapeutics stock jumps on FDA filing for Phase 2a colorectal cancer trial

Ciena stock price swings on S&P 500 call-up, with Feb. 9 and March 5 in focus
Next Story

Ciena stock price swings on S&P 500 call-up, with Feb. 9 and March 5 in focus

Go toTop